Über

Joseph Kaserman, MD is a board-certified pulmonologist at Boston Medical Center (BMC) and an assistant professor of Pulmonary, Allergy, Sleep & Critical Care Medicine at Boston University Chobanian and Avedisian School of Medicine. Dr Kaserman is an established researcher in the Wilson Lab at the Center for Regenerative Medicine of Boston University and BMC. His research focuses on the use of gene editing technology to develop potential new treatments for Alpha-1 Antitrypsin Deficiency, a genetic disease that may result in serious lung disease in adults and/or liver disease at any age. He has been recognized for his work in this area, including receiving the inaugural John W. Walsh Translational Research Award in 2018.

  • Departments

  • Specialties

    Alpha-1 Antitrypsin Deficiency

  • Administrative Title

    Assistant Professor, Pulmonary, Allergy, Sleep & Critical Care Medicine, Boston University Chobanian and Avedisian School of Medicine

  • Residency

    Internal Medicine, Brown University, 2010-2013
  • Fellowship

    Pulmonary Disease and Critical Care Medicine, Boston University Medical Center, 2013-2017
  • Board Certifications

    Critical Care Medicine, Pulmonary Disease and Internal Medicine, American Board of Internal Medicine